2,024
Views
0
CrossRef citations to date
0
Altmetric
Perspective

State of Cancer Care in India and Opportunities for Innovation

, , , , ORCID Icon, & show all
Pages 2593-2606 | Received 17 Jan 2023, Accepted 17 Jul 2023, Published online: 07 Sep 2023

References

  • American Cancer Society . Global Cancer Facts & Figures (4th Edition).American Cancer Society, Atlanta, USA (2018).
  • WHO, International Agency for Research on Cancer . Estimated number of deaths in 2020, all cancers, both sexes, all ages. Cancer Today. (2020). https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=population&mode_population=income&population=900&populations=900&key=total&sex=0&cancer=39&type=1&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&half_pie=0&donut=0 (Accessed 14092022).
  • Sung H , FerlayJ, SiegelRLet al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin.71(3), 209–249 (2021).
  • Global Cancer Observatory . Cancer Today.International Agency for Research on Cancer (2020). gco.iarc.fr/today (Accessed 14092022).
  • Gulia S , SengarM, BadweR, GuptaS. National Cancer Control Programme in India: Proposal for Organization of Chemotherapy and Systemic Therapy Services. J Glob Oncol3(3), 271–274 (2017).
  • Institute for Health Metrics and Evaluation . https://vizhub.healthdata.org/gbd-compare/
  • Global Burden of Disease 2019 Cancer Collaboration . KocarnikJM, ComptonKet al.Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol8(3), 420–444 (2022).
  • Kadam YR , QuraishiSR, DhobleRV, SawantMR, GoreAD. Barriers for Early Detection of Cancer Amongst Urban Indian Women: A Cross Sectional Study. Iran J Cancer Prev9(1), e3900 (2016).
  • Tripathi N , KadamYR, DhobaleRV, GoreAD. Barriers for early detection of cancer amongst Indian rural women. South Asian J Cancer3(2), 122–127 (2014).
  • Kulothungan V , SathishkumarK, LeburuSet al. Burden of cancers in India - estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program. BMC Cancer22(1), 527 (2022).
  • Sengar M , FundytusA, HopmanWMet al. Medical oncology in India: workload, infrastructure, and delivery of care. Indian Journal of Medical and Paediatric Oncology40(1), 121–127 (2019).
  • Mathur P , SathishkumarK, ChaturvediMet al. Cancer Statistics, 2020: Report From National Cancer Registry Programme, India. JCO Glob Oncol6, 1063–1075 (2020).
  • Singh M , PrasadCP, SinghTD, KumarL. Cancer research in India: challenges & opportunities. Indian J. Med. Res.148(4), 362–365 (2018).
  • Sullivan R , BadweRA, RathGKet al. Cancer research in India: national priorities, global results. Lancet Oncol15(6), e213–222 (2014).
  • WCRF International . www.wcrf.org/cancer-trends/global-cancer-data-by-country/
  • Williams J , AllenL, WickramasingheK, MikkelsenB, RobertsN, TownsendN. A systematic review of associations between non-communicable diseases and socioeconomic status within low- and lower-middle-income countries. J Glob Health8(2), doi: 10.7189/jogh.08.020409 (2018).
  • Finke I , BehrensG, WeisserL, BrennerH, JansenL. Socioeconomic Differences and Lung Cancer Survival-Systematic Review and Meta-Analysis. Front Oncol8, 536 (2018).
  • Arora A , SinghSP, SiddiquiMZ. The new estimate of India's Multidimensional Poverty. doi: 10.13140/RG.2.2.32876.87681 (2018).
  • India State-Level Disease Burden Initiative Cancer Collaborators . The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016. Lancet Oncol19(10), 1289–1306 (2018).
  • Siegel RL , MillerKD, FuchsHE, JemalA. Cancer Statistics, 2021. CA Cancer J. Clin.71(1), 7–33 (2021).
  • Howlader N , ForjazG, MooradianMJet al. The Effect of Advances in Lung-Cancer Treatment on Population Mortality. N. Engl. J. Med.383(7), 640–649 (2020).
  • Waterhouse D , LamJ, BettsKAet al. Real-world outcomes of immunotherapy-based regimens in first-line advanced non-small cell lung cancer. Lung Cancer156, 41–49 (2021).
  • Mohan A , GargA, GuptaAet al. Clinical profile of lung cancer in North India: a 10-year analysis of 1862 patients from a tertiary care center. Lung India37(3), 190–197 (2020).
  • Fundytus A , SengarM, LombeDet al. Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey. Lancet Oncol22(10), 1367–1377 (2021).
  • Ravikrishna M , AbrahamG, PatilVMet al. Checkpoint inhibitor accessibility in 15,000+ Indian patients. Presented at: ASCO Annual Meeting.Chicago, USA (2022).
  • Sahu DP , SubbaSH, GiriPP. Cancer awareness and attitude towards cancer screening in India: a narrative review. J Family Med Prim Care9(5), 2214–2218 (2020).
  • Gupta A , ShridharK, DhillonPK. A review of breast cancer awareness among women in India: cancer literate or awareness deficit?Eur. J. Cancer51(14), 2058–2066 (2015).
  • Sankeshwari R , AnkolaA, HebbalM, MuttagiS, RawalN. Awareness regarding oral cancer and oral precancerous lesions among rural population of Belgaum district, India. Glob Health Promot23(3), 27–35 (2016).
  • Veerakumar AM , KarSS. Awareness and perceptions regarding common cancers among adult population in a rural area of Puducherry, India. J Educ Health Promot6, 38 (2017).
  • Nyblade L , StocktonM, TravassoS, KrishnanS. A qualitative exploration of cervical and breast cancer stigma in Karnataka, India. BMC Womens Health17(1), 58 (2017).
  • Chalkidou K , MarquezP, DhillonPKet al. Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries. Lancet Oncol15(3), e119–131 (2014).
  • Bagcchi S . India launches plan for national cancer screening programme. BMJ355, doi: 10.1136/bmj.i5574 (2016).
  • Monica , MishraR. An epidemiological study of cervical and breast screening in India: district-level analysis. BMC Womens Health20(1), 225 (2020).
  • Banavali SD . Delivery of cancer care in rural India: experiences of establishing a rural comprehensive cancer care facility. Indian J Med Paediatr Oncol36(2), 128–131 (2015).
  • Mallath MK , TaylorDG, BadweRAet al. The growing burden of cancer in India: epidemiology and social context. Lancet Oncol15(6), e205–212 (2014).
  • Datta SS , GhoseS, GhoshMet al. Journeys: understanding access, affordability and disruptions to cancer care in India. Ecancermedicalscience16, 1342 (2022).
  • Faruqui N , MartiniukA, SharmaAet al. Evaluating access to essential medicines for treating childhood cancers: a medicines availability, price and affordability study in New Delhi, India. BMJ Glob Health4(2), e001379 (2019).
  • Burnet NG , BensonRJ, WilliamsMV, PeacockJH. Improving cancer outcomes through radiotherapy. Lack of UK radiotherapy resources prejudices cancer outcomes. BMJ320(7229), 198–199 (2000).
  • Gupta M , SinghK. Steps to improve cancer treatment facilities especially radiotherapy infrastructure in India. J Cancer Res Ther18(1), 1–4 (2022).
  • Number of oncologists per one million people by select country 2018. www.statista.com/statistics/884711/oncologists-density-by-country-worldwide/
  • Saini KS , AgarwalG, JagannathanRet al. Challenges in launching multinational oncology clinical trials in India. South Asian J Cancer2(1), 44–49 (2013).
  • Dhankhar A , KumariR, BahurupiYA. Out-of-Pocket, Catastrophic Health Expenditure and Distress Financing on Non-Communicable Diseases in India: A Systematic Review with Meta-Analysis. Asian Pac J Cancer Prev22(3), 671–680 (2021).
  • Singh PK , SinghS. What is the cost of cancer care in India?The Week (2020). www.theweek.in/news/health/2020/02/26/what-is-the-cost-of-cancer-care-in-india.html
  • Chancel L , PikettyT, SaezE, ZucmanGet al. World Inequality Report 2022. World Inequality Lab, boulevard Jourdan, PARIS (2021).
  • Kastor A , MohantySK. Disease-specific out-of-pocket and catastrophic health expenditure on hospitalization in India: do Indian households face distress health financing?PLOS ONE13(5), e0196106 (2018).
  • Haitsma G , PatelH, GurumurthyP, PostmaMJ. Access to anti-cancer drugs in India: is there a need to revise reimbursement policies?Expert Rev Pharmacoecon Outcomes Res18(3), 289–296 (2018).
  • Aguiar PN Jr , HaalandB, ParkW, SanTan P, DelGiglio A, de Lima LopesGJr. Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer. JAMA Oncol4(8), 1080–1084 (2018).
  • Thakur S , ChakrabortyDS, LahiryS, ChoudhuryS. Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: opportunities and challenges in Indian scenario. Lung India37(1), 77–78 (2020).
  • Wells JC , SharmaS, DelPaggio JCet al. An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries. JAMA Oncol7(3), 379–385 (2021).
  • Chakraborty S , MallickI, LuuHNet al. Geographic disparities in access to cancer clinical trials in India. Ecancermedicalscience15, 1161 (2021).
  • Roy AM , MathewA. Audit of Cancer Clinical Trials in India. J Glob Oncol5, 1 (2019).
  • National Library of Medicine . https://clinicaltrials.gov/
  • Biswkarma VK , RohatgiN, SaxenaR, GuptaSK. Knowledge, attitudes, and perception of 398 cancer patients toward participation in clinical trials: a single-center study from New Delhi, India. Perspect Clin Res13(1), 43–47 (2022).
  • WHO . www.who.int/activities/preventing-cancer
  • Federation of Indian Chambers of Commerce & Industry in collaboration with Ernst & Young Global Limited . https://assets.ey.com/content/dam/ey-sites/ey-com/en_in/topics/health/2022/ey-making-quality-cancer-care-more-accessible-and-affordable-in-india.pdf
  • Rath GK , GandhiAK. National cancer control and registration program in India. Indian J Med Paediatr Oncol35(4), 288–290 (2014).
  • Parashar D . The role of non government organizations in cancer control programmes in developing countries. Indian Journal of Palliative Care10(2), (2004).
  • Schliemann D , SuTT, ParamasivamDet al. Effectiveness of Mass and Small Media Campaigns to Improve Cancer Awareness and Screening Rates in Asia: A Systematic Review. J Glob Oncol5, 1–20 (2019).
  • Plackett R , KaushalA, KassianosAPet al. Use of Social Media to Promote Cancer Screening and Early Diagnosis: Scoping Review. J Med Internet Res22(11), e21582 (2020).
  • Anbazhagan S , ShanbhagD, AntonyAet al. Comparison of effectiveness of two methods of health education on cancer awareness among adolescent school children in a rural area of Southern India. J Family Med Prim Care5(2), 430–434 (2016).
  • Budukh A , ShahS, KulkarniSet al. Tobacco and cancer awareness program among school children in rural areas of Ratnagiri district of Maharashtra state in India. Indian J. Cancer59(1), 80–86 (2022).
  • Sankaranarayanan R , RamadasK, ThomasGet al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet365(9475), 1927–1933 (2005).
  • Sankaranarayanan R , RamadasK, TharaSet al. Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India. Oral Oncol49(4), 314–321 (2013).
  • Sankaranarayanan R , NeneBM, ShastriSSet al. HPV screening for cervical cancer in rural India. N. Engl. J. Med.360(14), 1385–1394 (2009).
  • Sankaranarayanan R , EsmyPO, RajkumarRet al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet370(9585), 398–406 (2007).
  • Shastri SS , MittraI, MishraGAet al. Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. J. Natl Cancer Inst.106(3), doi: 10.1093/jnci/dju009 (2014).
  • Mittra I , MishraGA, DikshitRPet al. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai. BMJ372, doi: 10.1136/bmj.n256 (2021).
  • Budukh AM , DikshitR, ChaturvediP. Outcome of the randomized control screening trials on oral, cervix and breast cancer from India and way forward in COVID-19 pandemic situation. Int. J. Cancer149(8), 1619–1620 (2021).
  • Gopika MG , PrabhuPR, ThulaseedharanJV. Status of cancer screening in India: an alarm signal from the National Family Health Survey (NFHS-5). J Family Med Prim Care11(11), 7303–7307 (2022).
  • Department of Health Research . https://htain.icmr.org.in/diamonds
  • Extension for Community Healthcare Outcomes . www.echoindia.in/healthcare
  • National Health Authority . https://pmjay.gov.in/about-pmjay
  • National Health Authority . https://nha.gov.in/PM-JAY
  • Gupta D , SinghA, GuptaNet al. Cost-Effectiveness of the First Line Treatment Options For Metastatic Renal Cell Carcinoma in India. JCO Glob Oncol9, e2200246 (2023).
  • Gupta N , GuptaD, DixitJet al. Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women. Appl Health Econ Health Policy20(4), 609–621 (2022).
  • Gupta N , NehraP, ChauhanASet al. Cost Effectiveness of Bevacizumab Plus Chemotherapy for the Treatment of Advanced and Metastatic Cervical Cancer in India-A Model-Based Economic Analysis. JCO Glob Oncol8, e2100355 (2022).
  • Chopra R , LopesG. Improving Access to Cancer Treatments: The Role of Biosimilars. J Glob Oncol3(5), 596–610 (2017).
  • Natarajan A , MehraN, RajkumarT. Economic perspective of cancer treatment in India. Med. Oncol.37(11), 101 (2020).
  • Ranganathan P , ChinnaswamyG, SengarMet al. The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research. Lancet Oncol22(8), e369–e376 (2021).
  • National Cancer Grid . https://tmc.gov.in/ncg/index.php/research/bsnc
  • Pramesh CS , BadweRA, SinhaRK. The national cancer grid of India. Indian J Med Paediatr Oncol35(3), 226–227 (2014).
  • Patil VM , NoronhaV, MenonNet al. Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study. J. Clin. Oncol.41(2), 222–232 (2023).
  • Mitchell AP , GoldsteinDA. Cost Savings and Increased Access With Ultra-Low-Dose Immunotherapy. J. Clin. Oncol.41(2), 170–172 (2023).
  • HindustanTimes . www.hindustantimes.com/cities/mumbai-news/iitbtata-hosp-cancer-therapy-trials-show-promising-results-101662923174819.html
  • Burki TK . CAR T-cell therapy roll-out in low-income and middle-income countries. Lancet Haematol8(4), e252–e253 (2021).
  • Damani A , SalinsN, GhoshalAet al. Provision of palliative care in National Cancer Grid treatment centres in India: a cross-sectional gap analysis survey. BMJ Support Palliat Care, doi: 10.1136/bmjspcare-2019-002152 (2020).
  • Khosla D , PatelFD, SharmaSC. Palliative care in India: current progress and future needs. Indian J Palliat Care18(3), 149–154 (2012).
  • Annapurna SA , RaoSY. New drug and clinical trial rules, 2019: an overview. Int. J. Clin. Trials.7(4), 278–284 (2020).